释放可穿戴技术用于心血管疾病预防潜力的实施路径白皮书

From Innovation to Integration: TheRoute Towards Realising the Potential ROBERT BALLANTINE, Leader, Global Digital Health Centre of Excellence, IQVIAPHIL CHOWIENCZYK, Vice President, BIHSJESSICA EKEY, Director, Connected Devices Strategic Solutions Lead, IQVIAJULIA LEVY, CEO, PromomentaLYNN MACKAY-THOMAS, Strategic Lead, BIHS Table of contents Executive summary1Introduction: The potential of wearables in hypertension managementin the context of the NHS transformation2 Addressing the challenges3 Access and affordability: Wearable data for hypertension management in the UK3Creating a national evaluation architecture for wearable blood pressure devices6Driving performance and innovation by linking next generation BP devicesto clinical event data7From wrist to record: The challenges of integrating wearable data into Economics, policy and operationalisation: Making wearable BP monitoring Conclusion: Moving from vision to reality12 Set up data integration, performance and innovation, and validation workstreams12 care. The EU Safe Hearts Plan also recognises thepotential for wearables in personalised preventionand risk management, while identifying persistent Executive summary Cardiovascular Disease (CVD) is the UK’s leadingcause of premature death, with hypertension(chronically raised blood pressure) as the most Wearables are being increasingly used, although lesswell adopted by those at higher risk groups. To unlockthe full potential of wearables, it is essential to ensure Traditional cuff-based blood pressure monitors imposebarriers due to convenience and engagement issues, Wearable blood pressure technologies should not beadopted device by device or app by app; they needa proportionate national framework for evaluation, Wearable devices with advanced cardiovascularsensors promise continuous, unobtrusive monitoring,facilitating earlier diagnosis, empowering patients intheir own care, enhancing treatment adherence, and This paper proposes a roadmap to achievethis, transforming hypertension detection andmanagement, and supporting the NHS’s vision for Wearables thereby support the goals of the NHS10-Year Health Plan which prioritises a shift to Introduction: The potential of wearables in hypertensionmanagement in the context of the NHS transformation Cardiovascular Disease (CVD) is the leading causeof premature death in the UK with hypertension themost significant modifiable risk factor. Despite broadawareness campaigns, control rates remain low, andmillions of people — particularly those in working-age In November 2025, IQVIA and the British &Irish Hypertension Society (BIHS)co-hosted a High Level Summit on ‘Realisingthe Potential of Wearable BP Technology toPrevent Cardiovascular Disease’. The eventbrought together NHS England, DHSE, NICE, Effective blood pressure monitoring is thereforecrucial. Innovative wearable technology, equippedwith advanced cardiovascular sensors, offers thepromise of overcoming the limitations of traditional This white paper lays out the outcomes of A full report on the summit can be foundhere:https://bihs.org.uk/blood_pressure_technology/summit_2025.aspx Yet, realising this potential requires addressing criticalchallenges. Ensuring the reliability and clinical validity ofwearable devices, integrating their data seamlessly intoNHS digital infrastructure, and making the technology Wearables enable continuous, unobtrusive homemonitoring, but their potential goes beyondconvenience. These devices can empower patientsto take ownership of their health, support treatmentadherence, and enable collaborative self-managementalongside healthcare professionals. Unlike point-in- The NHS is not the only healthcare service to recognisethe potential of wearables for managing cardiovasculardisease. The EU Safe Hearts Plan launched in December2025 calls out the role of digital technologies andwithin these of consumer digital monitors in movingtowards personalised prevention and risk management Wearables align directly with NHS priorities, facilitatingimproved detection and control, shifting care into thecommunity, and enhancing digital integration across thecare pathway. They are also already used by significant The NHS 10-Year Health Plan for England sets out abold vision for the next decade, prioritising a shift fromhospital-centric to community-based care, from reactivetreatment to proactive prevention, and from analogue This paper sets out to create a roadmap towardsintegrating the use of wearables into standardNHS care and realising the potential of wearablesto truly transform hypertension detection and Addressing the challenges TYPES OF BLOOD PRESSURE The integration of wearables into hypertensionmanagement within the NHS faces several keychallenges. Ensuring the clinical reliability and validity ofthese devices is crucial, as is the seamless incorporationof wearable data into NHS digital systems. Accessibility Most cuff-based blood pressure measuringdevices used in